CTAS News Alert Cintas Corp (CTAS) 81.64 02/14/2015 20:12:54

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cintas Corp (CTAS) 81.64 $CTAS

Cintas Shares Up 36.5% Since SmarTrend's Buy Recommendation (CTAS)
Comtex SmarTrend(R) - Wed Feb 11, 4:46PM CST
SmarTrend identified an Uptrend for Cintas (NASDAQ:CTAS) on May 7th, 2014 at $59.29. In approximately 9 months, Cintas has returned 36.52% as of today's recent price of $80.94.
CTAS: 81.64 (-0.57)

Cintas Corporation to Sign Statement of Support for the Guard and Reserve
Business Wire - Tue Feb 10, 8:17AM CST
Employer Support of the Guard and Reserve (ESGR), a Department of Defense office, announced that twenty-six Cintas locations in fifteen states will participate in signing a Statement of Support for the Guard and Reserve on Tuesday, February 10th, 2015. Of those 26 locations, the Mason headquarters of the Cintas Corporation will participate in a signing that represents the company's longstanding commitment to helping employ National Guard and Reserve service members.
CTAS: 81.64 (-0.57)

Cintas Shines a Spotlight on School Janitors during Nationwide Contest
Business Wire - Mon Feb 09, 8:30AM CST
Do you know a janitor who works tirelessly to keep school grounds clean and safe for students, administration and staff? Want to show them some love? Starting today, Cintas Corporation (NASDAQ: CTAS) will once again hold a nationwide Janitor of the Year contest to recognize the best-of-the-best amongst school janitors. Created to shine a spotlight on those who work behind the scenes year-round to make schools a clean, safe and positive place, the contest will award $2,500 to the winning janitor and $2,500 in Cintas and Rubbermaid products and services to the school.
CTAS: 81.64 (-0.57)

Cintas Up 36.3% Since SmarTrend Uptrend Call (CTAS)
Comtex SmarTrend(R) - Wed Feb 04, 11:01AM CST
SmarTrend identified an Uptrend for Cintas (NASDAQ:CTAS) on May 7th, 2014 at $59.29. In approximately 9 months, Cintas has returned 36.28% as of today's recent price of $80.80.
CTAS: 81.64 (-0.57)

Dividend Aristocrats And A Fundamental Principle Of Dividend Growth Investing
Brian Ditchek - at Seeking Alpha - Tue Feb 03, 10:01AM CST

MKC: 74.64 (+0.33), GPC: 97.01 (+0.22), CAH: 86.08 (+0.04), ED: 63.92 (-1.69), SYY: 39.54 (-0.12), WMT: 85.81 (-0.08), GWW: 234.87 (+0.56), PNR: 66.87 (+1.09), TGT: 76.12 (-0.75), ABBV: 58.05 (+1.00), LOW: 72.05 (-0.14), BCR: 175.38 (+0.50), TROW: 82.45 (+0.17), VFC: 75.26 (+4.26), FDO: 77.86 (+0.31), HRL: 55.73 (+1.56), MHFI: 102.19 (unch), ADP: 88.75 (+1.00), ADM: 48.10 (+0.66), SIAL: 138.20 (+0.07), MCD: 95.65 (+0.56), DOV: 74.41 (+1.13), CVX: 112.78 (+1.92), SHW: 285.00 (+1.98), BF.B: 90.72 (-0.28), MMM: 165.94 (+0.03), BDX: 143.71 (+0.72), CLX: 109.00 (+0.74), MDT: 75.26 (+0.33), KMB: 111.00 (+0.82), XOM: 93.37 (+1.00), CB: 102.06 (+0.43), PEP: 99.13 (-1.14), SWK: 98.20 (+0.92), JNJ: 99.62 (+1.18), T: 34.66 (+0.05), CINF: 52.46 (+0.27), PPG: 236.77 (+3.74), APD: 152.81 (+0.59), ECL: 111.62 (+0.85), KO: 41.99 (-0.18), ABT: 46.09 (+0.87), HCP: 42.87 (+0.20), NUE: 48.90 (+0.55), EMR: 58.68 (+0.08), LEG: 44.90 (+0.17), ITW: 98.26 (+0.48), CTAS: 81.64 (-0.57), PG: 85.90 (-0.13), BEN: 53.91 (+0.23), AFL: 62.13 (+0.33), CL: 70.08 (+0.23)

How to Pick Winning Stocks When the Market is Going Down - Screen of the Week
Kevin Matras - Zacks Investment Research - Tue Feb 03, 12:00AM CST
How to Pick Winning Stocks When the Market is Going Down - Screen of the Week
ANW: 14.92 (+0.25), CTAS: 81.64 (-0.57), BRLI: 34.63 (+0.06), SCSS: 32.14 (+0.43), VMC: 79.87 (+0.46)

Cintas Appoints J. Michael Hansen as Chief Financial Officer
Business Wire - Mon Feb 02, 7:30AM CST
Cintas Corporation (NASDAQ: CTAS) announced today the appointment of J. Michael Hansen as Vice President and Chief Financial Officer for the $4.55 billion company. Hansen will report directly to Cintas' CEO, Scott D. Farmer, and will have responsibility for the company's financial operations. The appointment has been approved by Cintas' Board of Directors and is effective immediately.
CTAS: 81.64 (-0.57)

Getting Rich Slowly: An Investment Strategy
Gary McMurrin - at Seeking Alpha - Thu Jan 29, 4:52AM CST

HCP: 42.87 (+0.20), NUE: 48.90 (+0.55), CAH: 86.08 (+0.04), TROW: 82.45 (+0.17), ED: 63.92 (-1.69), VFC: 75.26 (+4.26), WMT: 85.81 (-0.08), GWW: 234.87 (+0.56), HRL: 55.73 (+1.56), T: 34.66 (+0.05), CTAS: 81.64 (-0.57), MCD: 95.65 (+0.56), CVX: 112.78 (+1.92), BEN: 53.91 (+0.23), SHW: 285.00 (+1.98)

34.9% Return Seen to Date on SmarTrend Cintas Call (CTAS)
Comtex SmarTrend(R) - Wed Jan 28, 9:45AM CST
SmarTrend identified an Uptrend for Cintas (NASDAQ:CTAS) on May 7th, 2014 at $59.29. In approximately 9 months, Cintas has returned 34.88% as of today's recent price of $79.97.
CTAS: 81.64 (-0.57)

Cintas (CTAS) Strives to Improve Workplace Environment - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 22, 4:20PM CST
Leading business service provider Cintas Corporation (CTAS) recently offered tips for fighting workplace illness
YUME: 5.56 (+0.17), CTAS: 81.64 (-0.57), CLGX: 35.46 (+0.45), HCKT: 8.15 (+0.03)

Cintas Offers Four Tips for Fighting Workplace Illness
Business Wire - Wed Jan 21, 9:12AM CST
Chillier weather isn't the only dreaded winter guest. The Centers for Disease Control and Prevention (CDC) recently announced that the flu has reached epidemic levels in the U.S. due to a severe strain and a less effective flu vaccine.(1) To help organizations keep employees healthy amidst cold and flu season, Cintas Corporation (NASDAQ: CTAS), a leader in first-aid and safety programs, today announced four illness-fighting tips.
CTAS: 81.64 (-0.57)

Cintas Set to Possibly Pullback After Yesterday's Rally of 1.64%
Comtex SmarTrend(R) - Fri Jan 16, 5:06PM CST
Cintas (NASDAQ:CTAS) traded in a range yesterday that spanned from a low of $77.69 to a high of $78.95. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $78.26 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CTAS: 81.64 (-0.57)

Watch for Cintas to Potentially Pullback After Gaining 1.64% Yesterday
Comtex SmarTrend(R) - Fri Jan 16, 5:05PM CST
Cintas (NASDAQ:CTAS) traded in a range yesterday that spanned from a low of $77.69 to a high of $78.95. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $78.26 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CTAS: 81.64 (-0.57)

Cintas Enhances Share Buyback Plan by Additional $500M - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 14, 9:40AM CST
The board of directors of leading business services provider Cintas Corporation (CTAS) recently approved a plan to increase its share repurchase program by an additional $500 million.
CTAS: 81.64 (-0.57), FC: 18.12 (+0.14), STN: 26.21 (+0.11), HCKT: 8.15 (+0.03)

Cintas' board approves further buy back of up to USD500m common stock
M2 - Wed Jan 14, 6:49AM CST
Cintas Corporation (Nasdaq:CTAS), a provider of specialised services to businesses, disclosed on Wednesday that its board of directors authorised an additional share buy back programme for up to USD500m of the company's common stock at market prices.
CTAS: 81.64 (-0.57)

Industry Rank: Invest in a New Uniform - Zacks Industry Rank Analysis
John Blank - Zacks Investment Research - Wed Jan 14, 12:00AM CST
Industry Rank: Invest in a New Uniform - Zacks Industry Rank Analysis
CTAS: 81.64 (-0.57), GK: 72.34 (+0.31)

Cintas boosts buyback
Seeking Alpha - at Seeking Alpha - Tue Jan 13, 3:36PM CST

CTAS: 81.64 (-0.57)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 5

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Honeywell Aerospace Faces Legal Turbulence in Fraud Case

Updated Category News Views 2

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Continue Reading
Skiptown Expands in Georgia Amid Growing Demand

Updated Category News Views 15

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 2

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Montessori and Tech: A New Era of Integration

Updated Category News Views 16

Reimagining Montessori with Technology Let's take a stroll down the road less traveled—the intersection of Montessori education and tech. For over a century, Montessori schools have valued individual child development, autonomy, and a purpose-driven environment. But let's face it, their technology hasn't always had the same handcrafted finesse. That's where illumine...

Continue Reading
Fluence Energy Faces Major Lawsuit Amid $3B Loss

Updated Category News Views 9

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 17

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 15

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 2

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 14

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading

Top 5 Most Recently Viewed Articles

Leads Biolabs Spotlights Antibody Breakthrough at WCLC 2026

Updated Category News Views 7

It’s not every day you see a biopharma company in Nanjing making waves like Leads Biolabs right now. Their latest leap? The bispecific antibody, Opamtistomig, caught the spotlight at WCLC 2026. Performance during trials turned heads, especially with Response Rates previously reported. A Step into the Spotlight The breakthrough came when Leads Biolabs' PD-L1/4-1BB...

Continue Reading
Exploring TON Society's Vision for Community Consensus and Growth

Updated Category News Views 321

TON Society's Role in Enhancing Community Collaboration The TON Society stands at the forefront of supporting the decentralized TON community. This organization is focused on empowering developers, builders, and enthusiasts with the needed resources to facilitate collaboration and drive growth within the ecosystem. Recent Developments Announced by TON At a recent event,...

Continue Reading
Cooper Standard's Cost Management Fuels Resilience in Q3

Updated Category News Views 105

Cooper Standard Reports Third Quarter Performance Cooper Standard Holdings Inc. (NYSE: CPS) has announced its financial results for the most recent quarter, emphasizing effective management strategies that are yielding significant savings. The company focuses on ongoing operational excellence while navigating various market challenges. Key Financial Highlights for Q3 2024...

Continue Reading
CADCA Receives Funding to Enhance Health Infrastructure

Updated Category News Views 155

CADCA Awarded National Partners Cooperative Agreement Funding CADCA is excited to announce its recent award through the National Partners Cooperative Agreement, funded by the Centers for Disease Control and Prevention (CDC). This five-year opportunity aims to enhance public health infrastructure and workforce capacity while addressing critical public health priorities....

Continue Reading
AAR's Trax Chosen for Delta TechOps System Upgrade Initiative

Updated Category News Views 169

AAR's Trax Chosen for Delta TechOps System Upgrade Initiative AAR CORP. (NYSE: AIR), a prominent name in aviation services for both commercial and government sectors, has made a significant announcement regarding its subsidiary, Trax. Trax has been selected to modernize the maintenance and engineering systems at Delta TechOps. This partnership is set to bring...

Continue Reading